MarketCap
Facebook
X
Telegram
Land |
 Frankreich |
IPO-Jahr |
2017 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
31 M |
Marktkapitalisierung |
$ 27.7 M |
EBITDA (LTM) |
$ -71.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
-6.02 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Lumos Pharma
LUMO
|
- | - | $ 35.3 M | Nasdaq Global Select Market |  USA |
 |
Syros Pharmaceuticals
SYRS
|
- | -8.44 % | $ 3.4 M | Nasdaq Global Select Market | USA |
 |
Gamida Cell Ltd.
GMDA
|
- | -18.25 % | $ 5.04 M | Nasdaq Global Market |  Israel |
 |
GT Biopharma
GTBP
|
$ 4.5 | -7.02 % | $ 24.8 M | Nasdaq Capital Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
C4 Therapeutics
CCCC
|
$ 2.96 | -5.29 % | $ 245 M | Nasdaq Global Select Market | USA |
 |
Regeneron Pharmaceuticals
REGN
|
$ 904.05 | -2.86 % | $ 94.6 B | Nasdaq Global Select Market,SPB | USA |
 |
Codexis
CDXS
|
$ 1.02 | -5.56 % | $ 88.9 M | Nasdaq Global Select Market | USA |
 |
Celldex Therapeutics
CLDX
|
$ 28.24 | -5.65 % | $ 1.88 B | Nasdaq Global Select Market | USA |
 |
CorMedix
CRMD
|
$ 5.23 | -7.69 % | $ 377 K | Nasdaq Global Market | USA |
 |
CRISPR Therapeutics AG
CRSP
|
$ 48.49 | -6.34 % | $ 4.36 B | Nasdaq Global Market,SPB |  Schweiz |
 |
SIGA Technologies
SIGA
|
$ 2.98 | -5.56 % | $ 213 M | Nasdaq Global Select Market | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Curis
CRIS
|
$ 0.84 | -24.32 % | $ 11.1 M | Nasdaq Global Market | USA |
 |
Champions Oncology
CSBR
|
$ 4.79 | -0.83 % | $ 66.3 M | Nasdaq Capital Market | USA |
 |
Cytokinetics, Incorporated
CYTK
|
$ 54.5 | -14.31 % | $ 6.55 M | Nasdaq Global Select Market,SPB | USA |
 |
DiaMedica Therapeutics
DMAC
|
$ 9.03 | -16.16 % | $ 424 M | Nasdaq Capital Market | USA |
 |
Edesa Biotech
EDSA
|
$ 2.14 | -1.38 % | $ 12.1 M | Nasdaq Capital Market | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 13.88 | -8.86 % | $ 898 M | NYSE | USA |
 |
Evogene Ltd.
EVGN
|
$ 0.32 | -9.87 % | $ 2.52 M | Nasdaq Global Market | Israel |
 |
Exelixis
EXEL
|
$ 68.71 | -5.56 % | $ 18.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Xeris Pharmaceuticals
XERS
|
$ 13.16 | 25.76 % | $ 2.11 B | Nasdaq Global Select Market | USA |
 |
Fennec Pharmaceuticals
FENC
|
$ 9.35 | -9.66 % | $ 267 M | Nasdaq Capital Market | USA |
 |
AbbVie
ABBV
|
$ 288.16 | -2.26 % | $ 510 B | NYSE,SPB | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.58 | -5.39 % | $ 2.6 M | NYSE American | Israel |
 |
vTv Therapeutics
VTVT
|
$ 21.86 | -9.03 % | $ 86.4 M | Nasdaq Global Select Market | USA |
|
Forte Biosciences
FBRX
|
$ 76.99 | 0.03 % | $ 997 M | Nasdaq Capital Market | USA |
 |
AC Immune SA
ACIU
|
$ 2.11 | -7.86 % | $ 213 M | Nasdaq Global Market | Schweiz |
 |
Aldeyra Therapeutics
ALDX
|
$ 0.61 | -5.56 % | $ 36.6 M | Nasdaq Global Select Market | USA |
 |
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market |  Canada |
 |
AIM ImmunoTech
AIM
|
$ 0.15 | -4.97 % | $ 243 K | NYSE American | USA |
 |
Ascendis Pharma A/S
ASND
|
$ 252.45 | -2.12 % | $ 15.3 B | Nasdaq Global Select Market |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
$ 69.63 | -2.83 % | $ 1.4 B | Nasdaq Global Market,SPB | USA |
 |
Actinium Pharmaceuticals
ATNM
|
$ 1.31 | -7.09 % | $ 40.9 M | NYSE American | USA |
 |
Autolus Therapeutics plc
AUTL
|
$ 1.24 | -10.14 % | $ 330 M | Nasdaq Global Select Market |  Britain |
 |
BridgeBio Pharma
BBIO
|
$ 74.33 | -4.57 % | $ 14.2 B | Nasdaq Global Select Market,SPB | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
$ 7.51 | -8.92 % | $ 1.58 B | Nasdaq Global Select Market | USA |
 |
Bicycle Therapeutics plc
BCYC
|
$ 3.49 | -6.18 % | $ 242 M | Nasdaq Global Select Market | Britain |
 |
Coherus BioSciences
CHRS
|
$ 0.75 | -11.77 % | $ 87.9 M | Nasdaq Global Market | USA |
 |
Arcutis Biotherapeutics
ARQT
|
$ 27.01 | -20.69 % | $ 3.44 B | Nasdaq Global Select Market,SPB | USA |
 |
Cellectis S.A.
CLLS
|
$ 1.01 | -13.68 % | $ 101 M | Nasdaq Global Market | France |
 |
BeyondSpring
BYSI
|
$ 0.65 | -4.9 % | $ 26.7 M | Nasdaq Capital Market | USA |
 |
Alkermes plc
ALKS
|
$ 44.51 | -3.01 % | $ 7.33 B | Nasdaq Global Select Market |  Irlanda |
 |
Altimmune
ALT
|
$ 1.97 | -7.31 % | $ 174 M | Nasdaq Global Market | USA |
 |
Cardiff Oncology
CRDF
|
$ 0.76 | -13.05 % | $ 50.8 M | Nasdaq Capital Market | USA |
 |
Citius Pharmaceuticals
CTXR
|
$ 0.55 | -0.07 % | $ 6.09 M | Nasdaq Capital Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 9.34 | -14.08 % | $ 256 M | Nasdaq Global Market,SPB | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 57.46 | -6.8 % | $ 7.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Atara Biotherapeutics
ATRA
|
$ 8.04 | -3.94 % | $ 101 M | Nasdaq Global Select Market,SPB | USA |